» Articles » PMID: 32213501

Trajectories of Serum Sodium on In-Hospital and 1-Year Survival Among Hospitalized Patients

Overview
Specialty Nephrology
Date 2020 Mar 28
PMID 32213501
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Objectives: This study aimed to investigate the association between in-hospital trajectories of serum sodium and risk of in-hospital and 1-year mortality in patients in hospital.

Design, Setting, Participants, & Measurements: This is a single-center cohort study. All adult patients who were hospitalized from years 2011 through 2013 who had available admission serum sodium and at least three serum sodium measurements during hospitalization were included. The trend of serum sodium during hospitalization was analyzed using group-based trajectory modeling; the five main trajectories were grouped as follows: () stable normonatremia, () uncorrected hyponatremia, () borderline high serum sodium, () corrected hyponatremia, and () fluctuating serum sodium. The outcome of interest was in-hospital mortality and 1-year mortality. Stable normonatremia was used as the reference group for outcome comparison.

Results: A total of 43,539 patients were analyzed. Of these, 47% had stable normonatremia, 15% had uncorrected hyponatremia, 31% had borderline high serum sodium, 3% had corrected hyponatremia, and 5% had fluctuating serum sodium trajectory. In adjusted analysis, there was a higher in-hospital mortality among those with uncorrected hyponatremia (odds ratio [OR], 1.33; 95% CI, 1.06 to 1.67), borderline high serum sodium (OR, 1.66; 95% CI, 1.38 to 2.00), corrected hyponatremia (OR, 1.50; 95% CI, 1.02 to 2.20), and fluctuating serum sodium (OR, 4.61; 95% CI, 3.61 to 5.88), compared with those with the normonatremia trajectory. One-year mortality was higher among those with uncorrected hyponatremia (hazard ratio [HR], 1.28; 95% CI, 1.19 to 1.38), borderline high serum sodium (HR, 1.18; 95% CI, 1.11 to 1.26), corrected hyponatremia (HR, 1.24; 95% CI, 1.08 to 1.42), and fluctuating serum sodium (HR, 2.10; 95% CI, 1.89 to 2.33) compared with those with the normonatremia trajectory.

Conclusions: More than half of patients who had been hospitalized had an abnormal serum sodium trajectory during hospitalization. This study demonstrated that not only the absolute serum sodium levels but also their in-hospital trajectories were significantly associated with in-hospital and 1-year mortality. The highest in-hospital and 1-year mortality risk was associated with the fluctuating serum sodium trajectory.

Podcast: This article contains a podcast at https://www.asn-online.org/media/podcast/CJASN/2020_03_25_CJN.12281019.mp3.

Citing Articles

Association between serum sodium trajectory and mortality in patients with acute kidney injury: a retrospective cohort study.

Huang S, Li X, Chen B, Zhong Y, Li Y, Huang T BMC Nephrol. 2024; 25(1):152.

PMID: 38698368 PMC: 11067220. DOI: 10.1186/s12882-024-03586-y.


Trajectories of neutrophil-to-lymphocyte ratios during neoadjuvant chemotherapy correlate with short- and long-term outcomes in gastric cancer: a group-based trajectory analysis.

Zheng H, Wang F, Zhang L, Li P, Zheng C, Chen Q BMC Cancer. 2024; 24(1):226.

PMID: 38365617 PMC: 10873962. DOI: 10.1186/s12885-024-11950-2.


Mortality predictors of patients diagnosed with severe hyponatremia in the emergency department.

Gurbuz M, Acehan S, Satar S, Gulen M, Sevdimbas S, Ince C Ir J Med Sci. 2024; 193(3):1561-1572.

PMID: 38291136 DOI: 10.1007/s11845-024-03615-7.


Dynamic increase in myoglobin level is associated with poor prognosis in critically ill patients: a retrospective cohort study.

Liu Y, Jiang J, Yuan H, Wang L, Song W, Pei F Front Med (Lausanne). 2024; 10:1337403.

PMID: 38264034 PMC: 10804859. DOI: 10.3389/fmed.2023.1337403.


Association between serum sodium levels within 24 h of admission and all-cause mortality in critically ill patients with non-traumatic subarachnoid hemorrhage: a retrospective analysis of the MIMIC-IV database.

Liu J, Li J, Zhang Q, Wang L, Wang Y, Zhang J Front Neurol. 2023; 14:1234080.

PMID: 37780696 PMC: 10540434. DOI: 10.3389/fneur.2023.1234080.